Kebuzone
Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID)[1] that was used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA)[2].
Clinical data | |
---|---|
Routes of administration | intramuscular |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 70–100 hours |
Excretion | renal |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.011.560 |
Chemical and physical data | |
Formula | C19H18N2O3 |
Molar mass | 322.35782 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
|
References
- Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
- "NCATS Inxight: Drugs — KEBUZONE". drugs.ncats.io. Retrieved 2019-02-27.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.